Biotech, Food & Drug | The National Law Review

The National Law Review features a wide variety of content on issues important to life sciences companies, including biosimilars, biotechnology, medical devices, drug pricing, nanotechnology, and pharmaceuticals. Our content reviews the impact the latest legal changes have on these industries, such as the 21st Century Cures Act. With all of these areas, our content covers issues such as licensing and patents, intellectual property, due diligence, litigation and tax implications.

We also have legal expertise on marketing compliance, licensing and collaborations, and bringing new products to market. Additionally, the National Law Review is a source for all the latest legal news and regulatory compliance issues involving food and cosmetics safety and labeling requirements, activities of the Food and Drug Administration (“FDA”) and the US Department of Agriculture (“USDA”).

Date	Title	Organization
20 Jul	Will Employers Be Forced to Accommodate Employees Who Test Positive for Marijuana?	Jackson Lewis P.C.
20 Jul	Claim of Massachusetts Employee Fired for Medical Marijuana Use May Proceed, State High Court Rules	Jackson Lewis P.C.
20 Jul	Massachusetts: Medical Marijuana as Reasonable Accommodation in Workplace	Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
20 Jul	Food-Borne Illness Outbreaks: A Case Study	Keller and Heckman LLP
20 Jul	Understanding Bolar and Bolar-Like Exceptions in U.S. and Abroad – Part 1	Michael Best & Friedrich LLP
20 Jul	More Details Added to CA Bill Prohibiting Fluorinated Chemicals in Food Packaging	Keller and Heckman LLP
19 Jul	Millennium Pharm. v. Sandoz, Inc. – Revenge of the Chemical Judges	Schwegman, Lundberg & Woessner, P.A.
19 Jul	Massachusetts SJC: Medical Marijuana Users May Be Safe from Employer Discrimination	Morgan, Lewis & Bockius LLP
19 Jul	Massachusetts Supreme Judicial Court Issues Groundbreaking Decision Allowing Medical Marijuana User to Assert State Law Handicap Discrimination Claim	Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
19 Jul	Philly Soda Tax Opponents Appeal To PA Supreme Court	Keller and Heckman LLP
19 Jul	Protecting Plant Innovations: Patents in United States, Australia, and New Zealand	K&L Gates
18 Jul	Are Employers Going to be Required to Accommodate Medical Marijuana Use?	Squire Patton Boggs (US) LLP
18 Jul	New Maine Law Limits Manufacturer and Wholesaler Interactions with Health Care Professionals	McDermott Will & Emery
18 Jul	Lance Armstrong False Claims Act Suit Cycles Through Motions on Way to Trial	Cadwalader, Wickersham & Taft LLP
18 Jul	Coherus Challenges One AbbVie Humira Patent In Four PTAB Proceedings	Foley & Lardner LLP
18 Jul	CSPI Refiles Lawsuit Alleging Coca-Cola and ABA Deceived Consumers on Health Risks	Keller and Heckman LLP
17 Jul	Modified California Prop 65 Details Warning Requirements	Keller and Heckman LLP
17 Jul	Biosimilars in Europe	Sterne, Kessler, Goldstein & Fox P.L.L.C.
17 Jul	Impact of TC Heartland on ANDA and Biosimilar Litigation	Foley & Lardner LLP
17 Jul	You Can Dance If You Want To: Sandoz v. Amgen	Sterne, Kessler, Goldstein & Fox P.L.L.C.

July 21, 2017

Biotechnology, Life Sciences, Food and Drug Law News

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS

Upcoming Legal Education Events